Ho, D.-H.; Nam, D.; Seo, M.; Park, S.-W.; Seol, W.; Son, I.
LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss. Cells 2022, 11, 861.
https://doi.org/10.3390/cells11050861
AMA Style
Ho D-H, Nam D, Seo M, Park S-W, Seol W, Son I.
LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss. Cells. 2022; 11(5):861.
https://doi.org/10.3390/cells11050861
Chicago/Turabian Style
Ho, Dong-Hwan, Daleum Nam, Mikyoung Seo, Sung-Woo Park, Wongi Seol, and Ilhong Son.
2022. "LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss" Cells 11, no. 5: 861.
https://doi.org/10.3390/cells11050861
APA Style
Ho, D.-H., Nam, D., Seo, M., Park, S.-W., Seol, W., & Son, I.
(2022). LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss. Cells, 11(5), 861.
https://doi.org/10.3390/cells11050861